Physician profile
Charles M Lash
NPI 1669573978
$6,097.80
in general payments reported to CMS, 2019-2025
29 companies · $2,074 in 2025
The $2,074 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $283 · 2021: $893 · 2022: $1,551 · 2023: $478 · 2024: $230 · 2025: $2,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.42 |
| Travel and Lodging | $1,011.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,560.68 | 2020-2024 | Axonics |
| Procept Biorobotics Corporation | $1,444.20 | 2025 | |
| Teleflex LLC | $623.98 | 2021-2025 | Barrigel, Urolift |
| Dendreon Pharmaceuticals LLC | $392.75 | 2019 | |
| Blue Earth Diagnostics | $346.05 | 2022-2025 | Posluma |
| Astellas Pharma US INC | $191.39 | 2019-2023 | Myrbetriq |
| Tela Bio, INC. | $155.08 | 2019-2021 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $135.90 | 2021-2025 | Interstim |
| Tolmar Pharmaceuticals, INC. | $130.27 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $125.71 | 2020 | |
| Organogenesis INC. | $121.85 | 2024 | Nushield |
| Endo Pharmaceuticals INC. | $107.50 | 2019-2021 | |
| Janssen Biotech, INC. | $103.31 | 2019-2021 | |
| Abbvie INC. | $88.57 | 2022-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $87.17 | 2020-2024 | Bard Urinary Drainage Bag, Personal Catheter Intermittent Catheter |
| Myriad Genetic Laboratories, INC. | $75.41 | 2022-2024 | Prolaris |
| Coloplast Corp | $51.78 | 2019-2025 | |
| Laborie Medical Technologies Corp. | $33.72 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $29.45 | 2019-2023 | |
| Rochester Medical Corporation | $29.45 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.81 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.31 | 2024 | |
| Allergan, INC. | $15.47 | 2020 | |
| Medtronic USA, INC. | $14.55 | 2019 | |
| Myovant Sciences INC. | $13.73 | 2021 | |
| Cook Medical LLC | $13.12 | 2021 | |
| Richard Wolf Medical Instruments Corp. | $12.27 | 2019 | |
| Ethicon US, LLC | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.